APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phenprocoumon

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Phenprocoumon Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchPhenprocoumon Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Phenprocoumon Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Phenprocoumon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phenprocoumon Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Phenprocoumon Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Phenprocoumon market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Phenprocoumon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phenprocoumon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phenprocoumon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Phenprocoumon market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Phenprocoumon market include Teva, Novartis, Mylan, Roche, Wörwag Pharma, Divis Labs, Aspen Pharmacare and Acis Arzneimittel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Phenprocoumon market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phenprocoumon and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phenprocoumon sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Phenprocoumon market size, projected growth trends, production technologies, key applications, and end-use industries.

Phenprocoumon Segment by Company

Teva

Novartis

Mylan

Roche

Wörwag Pharma

Divis Labs

Aspen Pharmacare

Acis Arzneimittel

Phenprocoumon Segment by Type

5 mg

10 mg

25 mg

50 mg

Phenprocoumon Segment by Application

Pulmonary Embolism

Venous Thrombosis

Thromboembolism

Others

Phenprocoumon Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Phenprocoumon status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Phenprocoumon market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Phenprocoumon significant trends, drivers, influence factors in global and regions.

6. To analyze Phenprocoumon competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenprocoumon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phenprocoumon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenprocoumon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Phenprocoumon market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phenprocoumon industry.

Chapter 3: Detailed analysis of Phenprocoumon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Phenprocoumon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Phenprocoumon in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Phenprocoumon Industry Trends Table 2. Phenprocoumon Industry Drivers Table 3. Phenprocoumon Industry Opportunities and Challenges Table 4. Phenprocoumon Industry Restraints Table 5. Global Phenprocoumon Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Phenprocoumon Revenue Share by Company (2021-2026) Table 7. Global Phenprocoumon Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Phenprocoumon Sales Volume Share by Company (2021-2026) Table 9. Global Phenprocoumon Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Phenprocoumon Company Ranking, (2024-2026) & (USD Million) Table 11. Global Phenprocoumon Key Company Manufacturing Base & Headquarters Table 12. Global Phenprocoumon Company, Product Type & Application Table 13. Global Phenprocoumon Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Phenprocoumon by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5 mg Table 18. Significant Companies of 10 mg Table 19. Significant Companies of 25 mg Table 20. Significant Companies of 50 mg Table 21. Global Phenprocoumon Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Phenprocoumon Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Phenprocoumon Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Phenprocoumon Sales Volume Share by Type (2021-2026) Table 25. Global Phenprocoumon Sales Volume Share by Type (2027-2032) Table 26. Global Phenprocoumon Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Phenprocoumon Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Phenprocoumon Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Phenprocoumon Sales Value Share by Type (2021-2026) Table 30. Global Phenprocoumon Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pulmonary Embolism Table 32. Significant Companies of Venous Thrombosis Table 33. Significant Companies of Thromboembolism Table 34. Significant Companies of Others Table 35. Global Phenprocoumon Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Phenprocoumon Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Phenprocoumon Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Phenprocoumon Sales Volume Share by Application (2021-2026) Table 39. Global Phenprocoumon Sales Volume Share by Application (2027-2032) Table 40. Global Phenprocoumon Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Phenprocoumon Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Phenprocoumon Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Phenprocoumon Sales Value Share by Application (2021-2026) Table 44. Global Phenprocoumon Sales Value Share by Application (2027-2032) Table 45. Global Phenprocoumon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Phenprocoumon Sales by Region (2021-2026) & (K Units) Table 47. Global Phenprocoumon Sales Market Share by Region (2021-2026) Table 48. Global Phenprocoumon Sales by Region (2027-2032) & (K Units) Table 49. Global Phenprocoumon Sales Market Share by Region (2027-2032) Table 50. Global Phenprocoumon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Phenprocoumon Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Phenprocoumon Sales Value Share by Region (2021-2026) Table 53. Global Phenprocoumon Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Phenprocoumon Sales Value Share by Region (2027-2032) Table 55. Global Phenprocoumon Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Phenprocoumon Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Phenprocoumon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Phenprocoumon Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 60. Global Phenprocoumon Sales Market Share by Country (2021-2026) Table 61. Global Phenprocoumon Sales by Country (2027-2032) & (K Units) Table 62. Global Phenprocoumon Sales Market Share by Country (2027-2032) Table 63. Global Phenprocoumon Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Phenprocoumon Sales Value Market Share by Country (2021-2026) Table 65. Global Phenprocoumon Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Phenprocoumon Sales Value Market Share by Country (2027-2032) Table 67. Teva Company Information Table 68. Teva Business Overview Table 69. Teva Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Teva Phenprocoumon Product Portfolio Table 71. Teva Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Phenprocoumon Product Portfolio Table 76. Novartis Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Mylan Phenprocoumon Product Portfolio Table 81. Mylan Recent Development Table 82. Roche Company Information Table 83. Roche Business Overview Table 84. Roche Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Roche Phenprocoumon Product Portfolio Table 86. Roche Recent Development Table 87. Wörwag Pharma Company Information Table 88. Wörwag Pharma Business Overview Table 89. Wörwag Pharma Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Wörwag Pharma Phenprocoumon Product Portfolio Table 91. Wörwag Pharma Recent Development Table 92. Divis Labs Company Information Table 93. Divis Labs Business Overview Table 94. Divis Labs Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Divis Labs Phenprocoumon Product Portfolio Table 96. Divis Labs Recent Development Table 97. Aspen Pharmacare Company Information Table 98. Aspen Pharmacare Business Overview Table 99. Aspen Pharmacare Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Aspen Pharmacare Phenprocoumon Product Portfolio Table 101. Aspen Pharmacare Recent Development Table 102. Acis Arzneimittel Company Information Table 103. Acis Arzneimittel Business Overview Table 104. Acis Arzneimittel Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Acis Arzneimittel Phenprocoumon Product Portfolio Table 106. Acis Arzneimittel Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Phenprocoumon Distributors List Table 110. Phenprocoumon Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Phenprocoumon Product Image Figure 2. Global Phenprocoumon Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phenprocoumon Sales Value (2021-2032) & (US$ Million) Figure 4. Global Phenprocoumon Sales (2021-2032) & (K Units) Figure 5. Global Phenprocoumon Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Phenprocoumon Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5 mg Image Figure 10. 10 mg Image Figure 11. 25 mg Image Figure 12. 50 mg Image Figure 13. Global Phenprocoumon Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Phenprocoumon Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Phenprocoumon Sales Volume Share by Type (2021-2032) Figure 16. Global Phenprocoumon Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Phenprocoumon Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Phenprocoumon Sales Value Share by Type (2021-2032) Figure 19. Pulmonary Embolism Image Figure 20. Venous Thrombosis Image Figure 21. Thromboembolism Image Figure 22. Others Image Figure 23. Global Phenprocoumon Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Phenprocoumon Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Phenprocoumon Sales Volume Share by Application (2021-2032) Figure 26. Global Phenprocoumon Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Phenprocoumon Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Phenprocoumon Sales Value Share by Application (2021-2032) Figure 29. Global Phenprocoumon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Phenprocoumon Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Phenprocoumon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Phenprocoumon Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Phenprocoumon Sales Value (2021-2032) & (US$ Million) Figure 34. North America Phenprocoumon Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Phenprocoumon Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Phenprocoumon Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Phenprocoumon Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Phenprocoumon Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Phenprocoumon Sales Value (2021-2032) & (US$ Million) Figure 40. South America Phenprocoumon Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Phenprocoumon Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Phenprocoumon Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Phenprocoumon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Phenprocoumon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Phenprocoumon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Phenprocoumon Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Phenprocoumon Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 10 mg
  • 25 mg
  • 50 mg
Applications
  • Pulmonary Embolism
  • Venous Thrombosis
  • Thromboembolism
  • Others
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Roche
  • Wörwag Pharma
  • Divis Labs
  • Aspen Pharmacare
  • Acis Arzneimittel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phenprocoumon Sales Value (2021-2032)
  4. 1.2.2 Global Phenprocoumon Sales Volume (2021-2032)
  5. 1.2.3 Global Phenprocoumon Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Phenprocoumon Market Dynamics
  1. 2.1 Phenprocoumon Industry Trends
  2. 2.2 Phenprocoumon Industry Drivers
  3. 2.3 Phenprocoumon Industry Opportunities and Challenges
  4. 2.4 Phenprocoumon Industry Restraints
3 Phenprocoumon Market by Company
  1. 3.1 Global Phenprocoumon Company Revenue Ranking in 2025
  2. 3.2 Global Phenprocoumon Revenue by Company (2021-2026)
  3. 3.3 Global Phenprocoumon Sales Volume by Company (2021-2026)
  4. 3.4 Global Phenprocoumon Average Price by Company (2021-2026)
  5. 3.5 Global Phenprocoumon Company Ranking (2024-2026)
  6. 3.6 Global Phenprocoumon Company Manufacturing Base and Headquarters
  7. 3.7 Global Phenprocoumon Company Product Type and Application
  8. 3.8 Global Phenprocoumon Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Phenprocoumon Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Phenprocoumon Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Phenprocoumon Market by Type
  1. 4.1 Phenprocoumon Type Introduction
  2. 4.1.1 5 mg
  3. 4.1.2 10 mg
  4. 4.1.3 25 mg
  5. 4.1.4 50 mg
  6. 4.2 Global Phenprocoumon Sales Volume by Type
  7. 4.2.1 Global Phenprocoumon Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Phenprocoumon Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Phenprocoumon Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Phenprocoumon Sales Value by Type
  11. 4.3.1 Global Phenprocoumon Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Phenprocoumon Sales Value by Type (2021-2032)
  13. 4.3.3 Global Phenprocoumon Sales Value Share by Type (2021-2032)
5 Phenprocoumon Market by Application
  1. 5.1 Phenprocoumon Application Introduction
  2. 5.1.1 Pulmonary Embolism
  3. 5.1.2 Venous Thrombosis
  4. 5.1.3 Thromboembolism
  5. 5.1.4 Others
  6. 5.2 Global Phenprocoumon Sales Volume by Application
  7. 5.2.1 Global Phenprocoumon Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Phenprocoumon Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Phenprocoumon Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Phenprocoumon Sales Value by Application
  11. 5.3.1 Global Phenprocoumon Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Phenprocoumon Sales Value by Application (2021-2032)
  13. 5.3.3 Global Phenprocoumon Sales Value Share by Application (2021-2032)
6 Phenprocoumon Regional Sales and Value Analysis
  1. 6.1 Global Phenprocoumon Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phenprocoumon Sales by Region (2021-2032)
  3. 6.2.1 Global Phenprocoumon Sales by Region: 2021-2026
  4. 6.2.2 Global Phenprocoumon Sales by Region (2027-2032)
  5. 6.3 Global Phenprocoumon Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Phenprocoumon Sales Value by Region (2021-2032)
  7. 6.4.1 Global Phenprocoumon Sales Value by Region: 2021-2026
  8. 6.4.2 Global Phenprocoumon Sales Value by Region (2027-2032)
  9. 6.5 Global Phenprocoumon Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Phenprocoumon Sales Value (2021-2032)
  12. 6.6.2 North America Phenprocoumon Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Phenprocoumon Sales Value (2021-2032)
  15. 6.7.2 Europe Phenprocoumon Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Phenprocoumon Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Phenprocoumon Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Phenprocoumon Sales Value (2021-2032)
  21. 6.9.2 South America Phenprocoumon Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Phenprocoumon Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Phenprocoumon Sales Value Share by Country, 2025 VS 2032
7 Phenprocoumon Country-level Sales and Value Analysis
  1. 7.1 Global Phenprocoumon Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Phenprocoumon Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Phenprocoumon Sales by Country (2021-2032)
  4. 7.3.1 Global Phenprocoumon Sales by Country (2021-2026)
  5. 7.3.2 Global Phenprocoumon Sales by Country (2027-2032)
  6. 7.4 Global Phenprocoumon Sales Value by Country (2021-2032)
  7. 7.4.1 Global Phenprocoumon Sales Value by Country (2021-2026)
  8. 7.4.2 Global Phenprocoumon Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Phenprocoumon Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Phenprocoumon Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Phenprocoumon Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Phenprocoumon Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Phenprocoumon Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Phenprocoumon Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Phenprocoumon Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Phenprocoumon Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Phenprocoumon Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Phenprocoumon Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Phenprocoumon Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Phenprocoumon Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Phenprocoumon Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Phenprocoumon Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Phenprocoumon Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Phenprocoumon Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Phenprocoumon Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Phenprocoumon Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Phenprocoumon Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Phenprocoumon Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Phenprocoumon Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Phenprocoumon Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Phenprocoumon Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Phenprocoumon Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Phenprocoumon Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Phenprocoumon Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Phenprocoumon Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Phenprocoumon Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Phenprocoumon Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Phenprocoumon Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Phenprocoumon Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Phenprocoumon Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Phenprocoumon Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Phenprocoumon Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche Phenprocoumon Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Wörwag Pharma
  26. 8.5.1 Wörwag Pharma Company Information
  27. 8.5.2 Wörwag Pharma Business Overview
  28. 8.5.3 Wörwag Pharma Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wörwag Pharma Phenprocoumon Product Portfolio
  30. 8.5.5 Wörwag Pharma Recent Developments
  31. 8.6 Divis Labs
  32. 8.6.1 Divis Labs Company Information
  33. 8.6.2 Divis Labs Business Overview
  34. 8.6.3 Divis Labs Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Divis Labs Phenprocoumon Product Portfolio
  36. 8.6.5 Divis Labs Recent Developments
  37. 8.7 Aspen Pharmacare
  38. 8.7.1 Aspen Pharmacare Company Information
  39. 8.7.2 Aspen Pharmacare Business Overview
  40. 8.7.3 Aspen Pharmacare Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Aspen Pharmacare Phenprocoumon Product Portfolio
  42. 8.7.5 Aspen Pharmacare Recent Developments
  43. 8.8 Acis Arzneimittel
  44. 8.8.1 Acis Arzneimittel Company Information
  45. 8.8.2 Acis Arzneimittel Business Overview
  46. 8.8.3 Acis Arzneimittel Phenprocoumon Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Acis Arzneimittel Phenprocoumon Product Portfolio
  48. 8.8.5 Acis Arzneimittel Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Phenprocoumon Value Chain Analysis
  2. 9.1.1 Phenprocoumon Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Phenprocoumon Sales Mode & Process
  6. 9.2 Phenprocoumon Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Phenprocoumon Distributors
  9. 9.2.3 Phenprocoumon Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst